These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1386868)

  • 21. The effect of coenzyme Q10 on the action of phospholipase.
    Sugiyama S; Hattori M; Nagai S; Takamura T; Ozawa T
    Arzneimittelforschung; 1985; 35(1):23-5. PubMed ID: 4039149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of a 32-kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mononuclear cells.
    Rothhut B; Comera C; Prieur B; Errasfa M; Minassian G; Russo-Marie F
    FEBS Lett; 1987 Jul; 219(1):169-75. PubMed ID: 2954855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of phospholipases A2 and C activities against dilauroylphosphorylcholine in mixed monolayers with semisynthetic derivatives of ganglioside and sphingosine.
    Perillo MA; Guidotti A; Costa E; Yu RK; Maggio B
    Mol Membr Biol; 1994; 11(2):119-26. PubMed ID: 7920864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2.
    Davidson FF; Dennis EA
    Biochem Pharmacol; 1989 Nov; 38(21):3645-51. PubMed ID: 2532012
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel mechanism of glucocorticosteroid (GC) action in suppression of phospholipase A2 (PLA2) activity stimulated by Ca2+ ionophore A23187: induction of protein phosphatases.
    Zor U; Her E; Braquet P; Ferber E; Reiss N
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():265-71. PubMed ID: 1847770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of pulmonary surfactant function by phospholipases.
    Holm BA; Keicher L; Liu MY; Sokolowski J; Enhorning G
    J Appl Physiol (1985); 1991 Jul; 71(1):317-21. PubMed ID: 1917756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipocortin-like anti-phospholipase A2 activity of endonexin.
    Fauvel J; Salles JP; Roques V; Chap H; Rochat H; Douste-Blazy L
    FEBS Lett; 1987 May; 216(1):45-50. PubMed ID: 2953628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of the putative PLA2-inhibiting sequence of annexin 1.
    Travé G; Lees D; Liautard JP; Widada JS
    FEBS Lett; 1991 Nov; 293(1-2):34-6. PubMed ID: 1835701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virtual lack of annexins in human platelets argues against a role in phospholipase A2 regulation and platelet secretion.
    Ferrières J; Simon MF; Fauvel J; Chap H
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):155-65. PubMed ID: 8012762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis.
    Bomalaski JS; Clark MA; Zurier RB
    Arthritis Rheum; 1986 Mar; 29(3):312-8. PubMed ID: 3964311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of a phospholipase A2 inhibitor in porcine serum.
    Nevalainen TJ; Evilampi OS
    J Biochem; 1984 Oct; 96(4):1303-5. PubMed ID: 6520125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion.
    Kim KM; Kim DK; Park YM; Kim CK; Na DS
    FEBS Lett; 1994 May; 343(3):251-5. PubMed ID: 8174710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I.
    Cartwright PH; Ilderton E; Sowden JM; Yardley HJ
    Br J Dermatol; 1989 Aug; 121(2):155-60. PubMed ID: 2528367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid assay for lipocortins using a continuous fluorescence displacement assay for phospholipase A2.
    Creaney A; Wilton DC
    Biochem Soc Trans; 1994 Aug; 22(3):306S. PubMed ID: 7821565
    [No Abstract]   [Full Text] [Related]  

  • 35. CD2 triggering stimulates a phospholipase A2 activity beside the phospholipase C pathway in human T lymphocytes.
    Le Gouvello S; Colard O; Theodorou I; Bismuth G; Tarantino N; Debre P
    J Immunol; 1990 Mar; 144(6):2359-64. PubMed ID: 1968928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline.
    Pruzanski W; Greenwald RA; Street IP; Laliberte F; Stefanski E; Vadas P
    Biochem Pharmacol; 1992 Sep; 44(6):1165-70. PubMed ID: 1417938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipases in biology and medicine.
    Kaiser E; Chiba P; Zaky K
    Clin Biochem; 1990 Oct; 23(5):349-70. PubMed ID: 2253331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membranes exert indirect negative control on phospholipase A2 in human placenta.
    Buhl WJ; Zipfel M; Garcia MT; Eisenlohr LM; Gehring U
    Eicosanoids; 1991; 4(4):235-44. PubMed ID: 1790000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical and immunological properties of 34kDa EDTA-extractable protein (EEP34k)].
    Ohta A; Ohsaka K; Nakayama R; Kobayashi R; Sakuragi S
    Nippon Ganka Gakkai Zasshi; 1989 Jun; 93(6):636-45. PubMed ID: 2530857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Fos is a surface pressure-dependent diverter of phospholipase activity.
    Borioli GA; Fanani ML; Caputto BL; Maggio B
    Biochem Biophys Res Commun; 2002 Jul; 295(4):964-9. PubMed ID: 12127989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.